Stockhouse.com uses cookies on this site. By continuing to use our service, you agree to our use of cookies. Cookies are used to offer you a better browsing experience and to analyze our traffic. We also use them to share usage information with our partners. See full details.
I Agree
×
Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Privacy Policy | Disclaimer

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Privacy Policy | Disclaimer
Please Try Again {{ error }}

Send my password

Return to Login
SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
News Focus
Silvercorp to Acquire Adventus Creating a Diversified Mining Company (click to learn more)
Quote  |  Bullboard  |  News  |  Opinion  |  Profile  |  Peers  |  Filings  |  Financials  |  Options  |  Price History  |  Ratios  |  Ownership  |  Insiders  |  Valuation

Stock Quote Today & Recent News Anavex Life Sciences Corp AVXL

Healthcare Biotechnology
Anavex Life Sciences Corp. is a clinical-stage biopharmaceutical company. The Company is engaged in the development of differentiated therapeutics by applying precision medicine to central nervous system (CNS) diseases with unmet need. The Company analyzes genomic data from clinical trials to identify biomarkers, which are used in the analysis of its clinical trials for the treatment of... see more
{{currentVideo.companyName}}
{{currentVideo.intervieweeName}}{{currentVideo.intervieweeTitle}}
{{currentVideo.headline}}
{{currentVideo.link1Text}}
{{currentVideo.link2Text}}
< Previous
{{moreVideoText}}
Next >

Current News (NDAQ:AVXL)

SHAREHOLDER ALERT: Anavex Life Sciences Sued for Securities Law Violations; Investors Should Contact Block & Leviton for More Information

Newsfile 7 hours ago

Shareholders that lost money on Anavex Life Sciences Corporation (AVXL) should contact Levi & Korsinsky about pending Class Action - AVXL

Accesswire 9 hours ago

Levi & Korsinsky Reminds Shareholders of a Lead Plaintiff Deadline of May 13, 2024 in Anavex Life Sciences Corporation Lawsuit - AVXL

Accesswire 9 hours ago

SHAREHOLDER ALERT: Pomerantz Law Firm Announces the Filing of a Class Action Against Anavex Life Sciences Corp. - AVXL

Accesswire 10 hours ago

INVESTOR ACTION NOTICE: The Schall Law Firm Encourages Investors in Anavex Life Sciences Corp. with Losses to Contact the Firm

Newsfile 11 hours ago

May 13, 2024 Deadline: Contact The Gross Law Firm to Join Class Action Suit Against AVXL

PR Newswire 16 hours ago

Shareholders that lost money on Anavex Life Sciences Corporation(AVXL) should contact Levi & Korsinsky about pending Class Action - AVXL

Accesswire 16 hours ago

Levi & Korsinsky Notifies Shareholders of Anavex Life Sciences Corporation (AVXL) of a Class Action Lawsuit and an Upcoming Deadline

Accesswire 16 hours ago

UPCOMING AVXL DEADLINE: Bronstein, Gewirtz & Grossman LLC Reminds Anavex Life Sciences Corp. Investors to Join the Class Action Lawsuit!

Accesswire 17 hours ago
View More News ››

Opinion & Analysis (NDAQ:AVXL)

Analyst Believes Biopharma's Alzheimer's Treatment Could Be Superior to Biogen's

Streetwise Reports December 11, 2019

EMA Opinion Bodes Well for Biopharma's Drug Getting Orphan Status

Streetwise Reports August 1, 2019
View More Opinion ››

Bullboard Posts (NDAQ:AVXL)

Not a lot of respect here….

For their data.  Seems like everyone is doubting efficacy.  But the approved products are NG also?  Well if the pharma...
hoffbag - November 25, 2023

$AVXL ANAVEX 2-73: A POTENTIAL BLOCKBUSTER DRUG IN THE MAKIN

$AVXL ANAVEX 2-73: A POTENTIAL BLOCKBUSTER DRUG IN THE MAKING!   https://www.aviseanalytics.com/anavex2-73-a-potential...
AviseAnalytics - June 30, 2021

AVXL 5 MOST PROMISING ALZHEIMER’S DISEASE STOCK!

5 MOST PROMISING ALZHEIMER’S DISEASE STOCK! https://www.aviseanalytics.com/5-most-promising-alzheimers-disease-stock/ ...
AviseAnalytics - June 22, 2021

ALL ABOARD

Dont miss this train leaving the station.............
billybob22 - February 4, 2021

End of Month - September 2020

End of the Month (EOM) report for November 2020 for Anavex Life Sciences Corp. - AVXL closed on 10/30/2020 at US$5.33 AVXL closed on 10...
R_J_ - December 2, 2020

End of Month - October 2020

End of the Month (EOM) report for October 2020 for Anavex Life Sciences Corp. - AVXL closed on 10/30/2020 at US$5.90 AVXL closed on 09/30...
R_J_ - October 31, 2020
View more Bullboard ››

BioVaxys Technology Corp.

BioVaxys Technology Corp.

BioVaxys Technology Corp. is a Canada-based clinical-stage biopharmaceutical company. The Company is focused on improving ...
View More »